English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51148419    ???header.onlineuser??? :  628
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"ann lii cheng"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 371-395 of 690  (28 Page(s) Totally)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-08-31T06:42:26Z Preoperative Prognostic Neurologic Index for Glioblastoma Patients Receiving Tumor Resection Liang H.-K.; Wang C.-W.; Tseng H.-M.; Huang C.-Y.; Lan K.-H.; Chen Y.-H.; You S.-L.; Cheng J.C.-H.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏 2021-08-31T06:42:26Z Type 2 diabetes mellitus is associated with increased mortality in chinese patients receiving curative surgery for colon cancer Chen K.-H.; Shao Y.-Y.; Lin Z.-Z.; Yeh Y.-C.; Wen-Yi S.; Kuo R.N.; Chen H.-M.; Lai C.-L.; Yeh K.-H.; ANN-LII CHENG; Lai M.-S.
臺大學術典藏 2021-08-31T06:42:26Z Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior Huang W.-T.; Kuo S.-H.; ANN-LII CHENG; Lin C.-W.
臺大學術典藏 2021-08-31T06:42:25Z Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:42:25Z No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen Chen T.W.-W.; Chen H.-M.; Lin C.-H.; Huang C.-S.; ANN-LII CHENG; Lai M.-S.; Lu Y.-S.
臺大學術典藏 2021-08-31T06:42:25Z Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma Liao F.; Hsu Y.-C.; Kuo S.-H.; Yang Y.-C.; Chen J.-P.; Hsu P.-N.; Lin C.-W.; Chen L.-T.; ANN-LII CHENG; Fann C.S.J.; Lin J.-T.; Wu M.-S.
臺大學術典藏 2021-08-31T06:42:24Z Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse Kuo S.-H.; Tsai H.-J.; Weng W.-H.; Li C.-C.; Yeh K.-H.; Chen L.-T.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:42:24Z Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity Chen M.-L.; Yan B.-S.; Lu W.-C.; Chen M.-H.; Yu S.-L.; Yang P.-C.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:42:24Z Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin Ou D.-L.; Lee B.-S.; Lin L.-I.; Liou J.-Y.; Liao S.-C.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:42:23Z Clinical activity of metronomic chemotherapy in liver cancers Shao Y.-Y.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-08-31T06:42:23Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:42:23Z Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy Shao Y.-Y.; Wu C.-H.; Lu L.-C.; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:42:23Z erratum: Oxidative stress enhances AXL-mediated cell migration through AKT1/Rac1-dependent mechanism (Free Radical Biology and Medicine (2013) 65 (1246-1256)) Huang J.-S.; Cho C.-Y.; Hong C.-C.; Yan M.-D.; Hsieh M.-C.; Lay J.-D.; Lai G.-M.; ANN-LII CHENG; Chuang S.-E.
臺大學術典藏 2021-08-31T06:42:22Z Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruption Lin Z.-Z.; Chou C.-H.; ANN-LII CHENG; Liu W.-L.; Chia-Hsien Cheng J.
臺大學術典藏 2021-08-31T06:42:22Z Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Hsu C.; Wu M.-S.; Tzeng Y.-S.; Tsai H.-J.; Wang H.-P.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:42:22Z A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; Yeh K.-H.; Lu Y.-S.; ANN-LII CHENG; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H.
臺大學術典藏 2021-08-31T06:42:21Z Dual Phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer Chen Y.-H.; Wei M.-F.; Wang C.-W.; Lee H.-W.; Pan S.-L.; Gao M.; Kuo S.-H.; ANN-LII CHENG; Teng C.-M.
臺大學術典藏 2021-08-31T06:42:21Z Recent advances in the prevention of hepatocellular carcinoma recurrence Lu L.-C.; ANN-LII CHENG; Poon R.T.P.
臺大學術典藏 2021-08-31T06:42:21Z Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensus ANN-LII CHENG; Li J.; Vaid A.K.; Ma B.B.Y.; Teh C.; Ahn J.B.; Bello M.; Charoentum C.; Chen L.-T.; De Lima Lopes G.; Jr.; Ho G.F.; Kong H.L.; Lam K.O.; Liu T.S.; Park Y.S.; Sriuranpong V.; Sudoyo A.W.; Wang J.-Y.; Zhang J.; Zhang S.Z.; Ciardiello F.; K?hne C.-H.; Shaw M.; Kim T.W.
臺大學術典藏 2021-08-31T06:42:21Z The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells Lin Y.-H.; Chen B.Y.-H.; Lai W.-T.; Wu S.-F.; Guh J.-H.; ANN-LII CHENG; Hsu L.-C.
臺大學術典藏 2021-08-31T06:42:20Z Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Wu M.-S.; Liou J.-M.; Tsai H.-J.; Tzeng Y.-S.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:42:20Z Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients Chang T.C.; Shiah H.S.; Yang C.H.; Yeh K.H.; ANN-LII CHENG; Shen B.N.; Wang Y.W.; Yeh C.G.; Chiang N.J.; Chang J.Y.; Chen L.T.
臺大學術典藏 2021-08-31T06:42:20Z Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinoma Liao B.-C.; Shao Y.-Y.; Chen H.-M.; Shau W.-Y.; Lin Z.-Z.; Kuo R.N.; Lai C.-L.; Chen K.-H.; ANN-LII CHENG; Yang J.C.-H.; Lai M.-S.
臺大學術典藏 2021-08-31T06:42:19Z Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma Tsai C.-L.; Hsu F.-M.; Tzen K.-Y.; Liu W.-L.; ANN-LII CHENG; Cheng J.C.-H.
臺大學術典藏 2021-08-31T06:42:19Z Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials Shao Y.-Y.; Shau W.-Y.; Chan S.-Y.; Lu L.-C.; Hsu C.-H.; ANN-LII CHENG

Showing items 371-395 of 690  (28 Page(s) Totally)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
View [10|25|50] records per page